ACAD News and Press, ACADIA Pharmaceuticals Inc. From 11/20/25

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at Citi’s 2025 Global Healthcare Conference on Tuesday, December 2, 2025 at 9:45 a.m. Eastern Time. A live webcast of Acadia’s fireside chat will be accessible on the company&#...

2025-11-14 17:28:43 ET More on 13F filings Seth Klarman's Baupost takes stake in Union Pacific, exits ViaSat, among Q3 trades Glenview adds new Pinterest, Zillow stakes, exits Wayfair, ON in Q3 moves Buffett's Berkshire Hathaway adds Google stake, exits D.R. Horton, ...

2025-11-10 16:31:34 ET ACADIA Pharmaceuticals Inc. (ACAD) UBS Global Healthcare Conference 2025 November 10, 2025 2:00 PM EST... Read the full article on Seeking Alpha For further details see: ACADIA Pharmaceuticals Inc. (ACAD) Presents at UBS Global Healthcare Conference 20...

2025-11-06 04:36:48 ET More on Acadia Pharma ACADIA Pharmaceuticals Inc. (ACAD) Q3 2025 Earnings Call Transcript ACADIA Pharmaceuticals Inc. 2025 Q3 - Results - Earnings Call Presentation ACADIA Pharmaceuticals: Nuplazid And Daybue Are Enough To Remain Bullish ...

2025-11-06 04:36:07 ET ACADIA Pharmaceuticals Inc. (ACAD) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: ACADIA Pharmaceuticals Inc. (ACAD) Q3 2025 Earnings Call Transcript

2025-11-05 16:13:47 ET More on Acadia Pharma ACADIA Pharmaceuticals: Nuplazid And Daybue Are Enough To Remain Bullish Acadia Pharmaceuticals: Reeling After PWS Failure - Downgrading To Hold ACADIA Pharmaceuticals Inc. (ACAD) Presents At Morgan Stanley 23rd Annual Glo...

- Third quarter total revenues of $278.6 million, up 11% year-over-year - Narrowing and raising high end of NUPLAZID ® net product sales guidance to $685 to $695 million - Updating DAYBUE ® net product sales guidance to $385 to $400 million Acadia Pha...

Curaleaf Holdings Inc (CURLF) is expected to report $-0.07 for Q3 2025 Southwest Gas Holdings Inc. (DE) (SWX) is expected to report $0.09 for Q3 2025 Terreno Realty Corporation (TRNO) is expected to report $0.65 for Q3 2025 Bio-Techne Corp (TECH) is expected to report $0.36 for Q1 202...

Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) breached their fiduciary duties ...

Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions Canada NewsWire Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER , Oct. 21, 2025 /CNW/ --  Equity Insider News Commentary – Conventi...